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Background: The purpose of this study was to evaluate the usefulness of diffusion-weighted magnetic resonance
imaging (DW-MRI) and positron emission tomography/computed tomography (PET/CT) in planning transthoracic
CT-guided biopsies of lung lesions.
Methods: Thirteen patients with lung lesions suspicious for malignancy underwent CT-guided biopsy. Chest
DW-MRI and apparent diffusion coefficient (ADC) calculation were performed to aid biopsy planning with fused
images. MRI was indicated due to large heterogeneous masses, association with lung atelectasis/consolidation/
necrosis, and/or divergent results of other biopsy type and histopathology versus clinical/radiological suspicion.
Eight patients underwent PET/CT to identify appropriate areas for biopsy.
Results: Mean patient (n = 9 males) age was 59 (range, 30 to 78) years. Based on DW-MRI results, biopsies targeted
the most suspicious areas within lesions. All biopsied areas showed higher DW signal intensity and lower ADCs
(mean, 0.79 (range, 0.54 to 1.2) × 10−3 mm2/s), suggesting high cellularity. In patients who underwent PET/CT,
areas with higher 18-fluorodeoxyglucose concentrations (standard uptake value mean, 7.7 (range, 3.6 to 13.7))
corresponded to areas of higher DW signal intensity and lower ADCs. All biopsies yielded adequate material for
histopathological diagnosis.
Conclusions: Functional imaging is useful for lung biopsy planning. DW-MRI and PET/CT increase overall
performance and enable the collection of adequate material for specific diagnosis.
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Percutaneous needle biopsy is considered to be reliable
for the evaluation of indeterminate lung lesions. Fine- or
cutting-needle biopsies can be performed with computed
tomographic (CT) guidance [1-3]. The high sensitivity
and specificity of the method and the low rate of compli-
cations have established cutting-needle biopsy as an effi-
cient and safe tool for the diagnosis of lung lesions [4].
Despite the high accuracy of this biopsy method, false-
negative results can occur, especially in large heteroge-
neous lesions with necrosis and those with associated
postobstructive atelectasis or consolidation.* Correspondence: marcosduarte500@gmail.com
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article, unless otherwise stated.In the current era of personalized medicine, advances
in oncological treatment have been based on targeted
therapy and molecular profiling, enabling the collection of
tissue specimens from regions representing a lesion’s most
aggressive behavior. For this reason, functional/metabolic
methods have been sought to enable the identification of
the most suspicious areas within a lesion for biopsy. In this
context, contrast-enhanced CT and 18-fluorodeoxyglucose
(18 F-FDG) positron emission tomography (PET)/CT have
been used for pre-biopsy lesion evaluation [5].
Recent advances in magnetic resonance imaging (MRI),
including the development of new functional methods
such as diffusion-weighted imaging (DWI), have expanded
the use of this modality for the evaluation of lung lesions
[6,7]. DWI evaluates the degree of cellularity throughout a
lesion, enabling differentiation of regions with high and
low degrees of cellularity through the analysis of watertral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
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for cancer treatment planning and response evaluation
[9,10]. MRI can also currently be used for lung cancer
screening and staging of lung malignancies [11,12].
The purpose of this study was to evaluate the useful-
ness of DW-MRI and PET/CT in the planning of trans-
thoracic CT-guided biopsies of lung lesions that are
suspicious for malignancy.
Methods
In this prospective study, 13 patients with pulmonary
lung lesions that were suspicious for malignancy based
on clinical and imaging findings and who were referred
for initial transthoracic CT-guided biopsy at our institu-
tion between July 2011 and August 2012, were evaluated.
All patients required further MRI evaluation, as deter-
mined by the following criteria: 1) presence of multiple
or large heterogeneous masses, 2) association of lesions
with lung atelectasis or consolidation in the adjacent
lung parenchyma, 3) invasion of the chest wall or medi-
astinal structures, 4) large-vessel involvement, and/or 5)
results of biopsy by another method that diverged from
clinical and radiological suspicion. No patient had previ-
ously undergone CT-guided biopsy that yielded inconclu-
sive results. The time interval of initial CT to pre-biopsy
MRI did not exceed 30 days in all cases. Screening coagu-
lation tests were ordered routinely and all patients under-
went chest MRI 1 h prior to biopsy to assist in procedure
planning. The institutional review board of AC Camargo
Cancer Center approved the study and all patients pro-
vided written informed consent.
MRI was performed with patients in the supine position
using a 1.5-T unit (Signa HDxt; General Electric Medical
Systems, Milwaukee, WI, USA) with a body phased-array
coil. Before DWI, axial T1- and T2-weighted fast spin-
echo images (repetition time/echo time, 6.3/2.7 ms and
3200/40 ms, respectively) with fat signal suppression, 6-
mm slice thickness, a 30-cm field of view, and a 256 ac-
quisition matrix were obtained. DWI was performed using
a multislice, single-shot, spin-echo and echo-planar im-
aging sequence in the transverse plane. DW images were
acquired with no gated sequence on the basis of prior T1-
and T2-weighted images; this sequence was performed
only in sections containing the pulmonary lesion during
breath holding. Pairs of motion-probing gradients were
applied before and after the 180° radiofrequency pulse of
the spin-echo T2-weighted sequence in three orthogonal
directions (X, Y, and Z). DW images were obtained at dif-
fusion factor (b) values of 0 and 600 s/mm2.
Apparent diffusion coefficient (ADC) maps were auto-
matically reconstructed for all DWI, and ADCs were mea-
sured after defining regions of interest (ROIs). Regions
within the lesions with the lowest ADCs were identified
for CT-guided biopsy.Post-contrast T1-weighted imaging was performed using
the same (pre-contrast) parameters and gadopentetate
dimeglumine (Magnevist; Berlex Laboratories, Wayne, NJ,
USA) paramagnetic contrast. A 20-ml dose was adminis-
tered at a rate of 2 ml/s using a power injector. For each
patient, panoramic acquisition of a scout image was
performed with 5 to 10-mm cuts for biopsy planning
purposes. Then, DW and CT images were fused using
Aquarius NET software (TeraRecon, Foster City, CA,
USA) to obtain corresponding plans. All image fusion pro-
cedures were very accurate displayed side-by-side, with
millimetric adjustments made by overlapping images in
the same plane and cut, considering at least three points
of common anatomical reference. An approach enabling
CT-guided direction of the needle tip to the region of
greatest cellularity, as identified by MRI performed 1 h
prior to the procedure, was chosen.
Eight patients in this study underwent PET/CT in the
week prior to the procedure according to clinical indica-
tion. PET/CT studies were interpreted by qualitatively
(visually) and quantitatively analyzing areas of anomal-
ous 18 F-FDG concentrations; quantitative analysis was
performed by measuring standard 18 F-FDG values or
standardized uptake values (SUVs) in anomalous areas.
According to the imaging department’s protocol, PET/CT
body scans (Gemini; Philips Medical Systems, Milpitas,
CA, USA) were acquired after patients received standard
intravenous doses of 560 MBq 18 F-FDG. The images
were obtained 1 h after radiotracer injection using a
high-sensitivity bi-dimensional mode with 10-mm axial
cuts and a 256 × 256 matrix. Tomographic image acqui-
sition parameters were 140 kVp, 120 to 200 mA, 0.8 s
per CT rotation, with 25-mm cuts and 3-mm thickness.
PET and CT images were analyzed together to identify
functional and anatomical correlations and sent for re-
construction using specific algorithms. The maximum
SUV was calculated by selecting the most representative
volumetric ROI within each tumor.
All biopsies were performed with a helical CT unit
(HiSpeed; General Electric Medical Systems) using the
cutting-needle biopsy technique with an automated 20-
gauge coaxial system (Angiotech, Vancouver, Canada).
Needles were 10 cm or 15 cm in length, depending on the
distance between the skin and the lesion. Local anesthesia
was administered routinely, and sedation was not neces-
sary in any case. At least five specimens were collected
from the single needle location chosen under MRI (DWI
and ADC) and PET/CT (18 F-FDG) guidance, when avail-
able, in each lesion. Biopsy specimens were subjected to
histological evaluation for specific diagnosis.
Results
Nine of the 13 patients were male and four were female
(mean age, 59 (range, 30 to 78) years). Table 1 summarizes
Table 1 Demographic data and imaging and
histopathological results in patients with lung lesions
submitted to percutaneous biopsy based on








38, male 50 0.61 - Metastasis from synovial
sarcoma
52, male 63 0.80 - Metastasis from
hypopharyngeal SCC
30, male 32 0.78 - Metastasis from melanoma
58, male 52 1.20 7.0 Carcinoid tumor
31, male 83 0.72 - High-grade sarcoma
62, female 28 0.79 5.7 Lung adenocarcinoma
69, male 39 0.74 - Lung SCC
76, female 76 0.99 3.6 Lung adenocarcinoma
76, male 20 0.88 10.1 Lung SCC
74, female 75 0.58 13.7 Lung SCC
78, female 24 0.74 5.5 Lung adenocarcinoma
63, male 67 0.54 9.6 Lung adenocarcinoma
62, male 80 0.96 6.6 Lung adenocarcinoma
aObtained at the lesion biopsy site. ADC, apparent diffusion coefficient;
SCC, squamous cell carcinoma; SUV, standard uptake value.
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characteristics of the lesions.
All lung biopsies provided adequate material, allowing
for specific histopathological diagnoses: lung adenocarcin-
oma (n = 5), squamous cell carcinoma (n = 3), carcinoidFigure 1 A 62-year-old man presenting with a heterogeneous mass in
fat-saturated T1-weighted and diffusion-weighted sequences. Magnetic res
portion (arrow) of the mass showed high signal intensity on the diffusion-w
composed of atelectasis, consolidation, or necrosis. (B) Computed tomogra
examination yielded a diagnosis of lung adenocarcinoma.tumor (n = 1), primary sarcoma (n = 1) and metastases
(n = 3; from synovial sarcoma, hypopharynx adenocarcin-
oma, and melanoma). No major complication was re-
ported after the procedure.
All biopsied areas showed higher signal intensity on
DWI sequences and correspondingly lower ADCs (mean,
0.79 (range, 0.54 to 1.2) × 10−3 mm2/s) in comparison with
other areas within the lesion, suggesting high degrees of
cellularity (Figures 1 and 2). Eight patients also underwent
PET/CT, and areas of higher 18 F-FDG concentrations on
PET/CT images (standard uptake value, SUV mean, 7.7
(range, 3.6 to 13.7)) corresponded to areas of higher signal
intensity on DWI sequences and lower ADCs in all cases
(Table 1).
Discussion
Within the context of contemporary oncology’s focus on
personalized medicine, most treatments are based on
targeted therapy and molecular profiling. Interventional
radiologists’ ability to collect tissue specimens that are
representative of tumor aggressiveness is thus increas-
ingly important. Functional imaging methods, such as
DWI and PET/CT, are key to the effectiveness of image-
guided percutaneous biopsies, obviating more invasive
procedures for proper diagnosis and therapeutic plan-
ning [5,13]. In the present study, all biopsies were per-
formed under functional imaging guidance, including
PET/CT and DWI, and provided adequate material for
analyses. Excellent results were obtained due to the
performance of accurate anatomical and functional im-
aging fusion prior to all procedures to identify areas bestthe superior lobe of the right lung. (A): Fusion of axial
onance imaging (MRI) demonstrated that only the anteromedial
eighted MRI sequence, suggesting that the rest of the mass may be
phy (CT)-guided biopsy was directed to this area, and histopathological
Figure 2 A 76-year-old woman presenting with a heterogeneous mass in the superior lobe of the right lung. (A) Fusion of axial
fat-saturated T1-weighted and diffusion-weighted sequences. Only the central-posterior portion (arrow) of the mass showed high signal intensity
on the diffusion-weighted magnetic resonance imaging (MRI) sequence, suggesting that the rest of the mass may be composed of atelectasis,
consolidation, or necrosis. (B) Computed tomography (CT)-guided biopsy was directed to this area, and histopathological examination yielded a
diagnosis of lung adenocarcinoma.
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enabled CT-guided direction of the needle tip to the re-
gion of greatest cellularity, previously identified by MRI
and PET/CT.
Biopsy has become a cornerstone of modern medicine,
and most modern biopsies are performed percutaneously
using image guidance, typically CT or ultrasound [4,15,16].
Recently, the use of MRI has grown to include guidance
for minimally invasive and open surgical procedures [16].
The aims of MRI guidance in all of these approaches are to
reduce the invasiveness of the procedure and improve the
diagnostic yield. MRI has some advantages in relation to
other image guidance techniques. First, MRI provides
unparalleled soft-tissue contrast and exquisite anatomic
detail, enabling the identification of target lesions that can-
not be observed with ultrasound or CT and the detailed
visualization of anatomy surrounding the target [17]. This
level of detail aids in preventing collateral damage to deli-
cate structures that typically would not be well visualized
using other imaging modalities. Additionally, MRI provides
the unique ability to identify different tissue characteristics
during a procedure with the use of different pulse se-
quences, which can range from simple T1 or T2 weighting
to more advanced functional information, such as flow,
perfusion, and diffusion [10,18].
In biological tissue, DWI signals are derived from the
motion of water molecules in the extracellular, intracel-
lular, and intravascular spaces. The degree of restriction
to water diffusion in biologic tissue is inversely corre-
lated with tissue cellularity and cell membrane integrity[6]. Recent studies have evaluated the use of DWI to
distinguish malignant from benign lesions [8]. Malignant
tumors have high degrees of cellularity with reduced
extracellular space, which decreases the diffusion of water,
resulting in higher DWI signal intensity and lower ADCs
[7,9]. In a review of 34 cases, Tondo et al. [8] showed that
DWI was useful in differentiating malignant from benign
lesions of the lung and mediastinum with 91% diagnostic
accuracy, 90% sensitivity, 100% specificity, a 100% positive
predictive value, and a 57% negative predictive value. Mori
et al. [19] compared DWI with PET/CT for the evaluation
of lung lesions and found that the methods had similar
sensitivities, but DWI had higher specificity and fewer
false-positive results than did PET/CT. According to
Regier et al. [20], ADCs are inversely correlated with max-
imum SUVs on PET/CT in non-small cell lung cancer.
PET/CT can also be used to plan lung lesion biopsies with
good diagnostic accuracy [5,21]. Nevertheless, further
studies are needed to assess whether DWI has equivalent
or better performance than PET/CT in the planning of
transthoracic biopsy of lung lesions. As both are consid-
ered functional images is possible that there is a strict
equivalence; however, this is an assumption. In the present
study, all 18 F-FDG avidity areas within lesions were corre-
lated with DWI/ADC data in eight patients who under-
went PET/CT.
Hoffmann et al. [22] reported on the accuracy, duration,
and factors influencing the use of MRI-guided biopsies.
Liu et al. [23] demonstrated that MRI-guided transtho-
racic biopsy has high levels of accuracy, sensitivity and
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diagnosis of small malignant nodules of less than 2.0 cm.
However, DWI can be time consuming and costly. Thus,
its use should be considered in complex cases, including
large, heterogeneous, and mixed-pattern lesions or in
severely debilitated patients. The time and cost require-
ments of this modality are justified in these special cases
because the collection of inadequate material for analysis
necessitates repetition of the procedure, increasing the
risk to the patient and overall cost. Another advantage of
MRI is the absence of risks of ionizing radiation, which is
usually present in the procedures performed by traditional
methods such as CT image and the PET/CT [24].
A few limitations of this study should be emphasized.
First, the patient sample was small. Second, no patient
underwent control or follow-up chest MRI. Third, the
establishment of an ADC cutoff value was not possible.
However, to our knowledge, this preliminary study is the
first to demonstrate the feasibility of using DW-MRI and
ADC in pulmonary lesions for procedure planning. Add-
itional studies are necessary to further evaluate the impact
of this technique on the diagnostic yield of transthoracic
lung biopsy, particularly in patients with large lesions and/
or severe illnesses.
Conclusions
In conclusion, functional imaging is a useful tool in lung
biopsy planning. DW-MRI and PET/CT increase overall
performance and enable the collection of adequate ma-
terial for specific diagnosis.
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